Skip to content
Home/Companies/Healthcare / Biotech/Mediar Therapeutics
Mediar Therapeutics

Mediar Therapeutics

Healthcare / Biotech·US·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Mediar Therapeutics?

Mediar Therapeutics is currently owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage), since 2021. Across its history, Mediar Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQUnited States
SectorHealthcare / Biotech
Websitewww.mediartx.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Sofinnova Partners and Gimv since 2021.
Co-invest · 2 holders · 2021 · present
Sofinnova Partners
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC
Gimv
GimvActive
2021 · present(5yr) · Gimv Portfolio

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals
Active
BiotechGermany· 2023
Freya Biosciences
Freya Biosciences
Active
BiotechDenmark· 2023
May Health
May Health
Active
MedTechFrance· 2023
Nuage Therapeutics
Nuage Therapeutics
Active
BiotechSpain· 2023
T-Therapeutics
T-Therapeutics
Active
BiotechUK· 2023
Catamaran Bio
Catamaran Bio
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Mediar Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Mediar Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue